FDA Investigator John P Mistler

John P Mistler has conducted inspections on 73 sites in 6 countries as of 18 Sep 2023. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
73
Last Inspection Date:
18 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
100001439
Countries of Inspections:
Lithuania, United States of America, India, Germany, Canada, Czechia
FDA Investigators that have inspected at least one site in common with John P Mistler:
Abby E Pelletier, Alan R Condon, Alice C Silva, Alison N Stieg, Alois P Provost, Amber G Wardwell, Amy C Jordan, Anastasia G Lolas, Anastasia I Onuorah, Andrew M Barlow, Anissa M Vargas, Anna Lazar, Anna M Brannen, Anne E Carpenter, Annet R Rajan, Anthony C Warchut, Arie C Menachem, Atul J Agrawal, Bo Chi, PhD, Brenda P King, Brooke K Higgins, Brooke K Seeman, Burnell M Henry, Byungja E Marciante, Camerson E Moore, Carl A Perez, Carla C Cummins, Carla C Tuite, Carlos Chavez, CDR Ileana Barreto Pettit, Chaltu Nwakijra, Charles Yuanchia Kuo, PhD, Charlotte Hinkle, Chiang Syin, PhD, Christopher Janik, Christopher T Middendorf, Constance Desimone, Courtney N Long, Cynthia Jim, CSO, Cynthia Whitmarsh, Daniel L Zheng, Danielle S Pearson, Darin S Wiegers, Daryl A Dewoskin, David P Vanhouten, Dawn M Braswell, Deborah J Parris, Demitria J Xiradakis, Dennis L Doupnik, Diane C Thibodeau, Diane T Bargo, Diane T O'brien, Dien N Nguyen, Dolores Harper, Don H Bark, PhD, Dorothy W Lee, Douglas A Campbell, Douglas C Kovacs, Dr. Barbara D Paul, PhD, Dr. Robert C Horan, MD, Dr. Sriram Subramaniam, PhD, Edmund F Mrak, Jr, Eliezar Ramos, Ellen P Madigan, Emest F Bizjak, Felix Maldonado, Garry H Stewart, Gary J Hagan, George M Ibrahim, George T Allen, Jr, Gerard D Difiore, Guerlain Ulysse, Haley H Seymour, Helen B Ricalde, Helen Verdel, Jacqueline Mdiaz Albertini, James L Dunnie, Jr, James M Mason, James P Mcevoy, Janet A Rajan, Jason A Rossi, Jawaid Hamid, Jayaleka J Amarasinghe, Jeffrey A Sommers, Jennifer T Szymanski, Jessica S Estriplet, Jianming Li, Jie He, Joan A Loreng, John J Thibodeau, John L Zaccone, John R Carlson, John S Hartford, Johnna L Bleem, Jonah S Ufferfilge, Jonathan G Matrisciano, Jonathan W Chapman, Jose Acruz Gonzalez, Juanita P Versace, Junho Pak, Justin A Boyd, Justine M Corson, Kalavati Suvarna, PhD, Karen E D'orazio, Karen L Kosar, Karen Mcnabb Noon, Karishma G Gopaul, Katelyn Astaub Zamperini, Kenneth H Williams, Kent A Conforti, Kip J Hanks, Ko U Min, Kristina J Donohue, Kshitij A Patkar, Lane V Christensen, PhD, Larry K Austin, Lashanda M Long, Lata C Mathew, PhD, Lauren N Barber, Laurie B Frazier, Lawrence J Stringer, LCDR Debra Emerson, LCDR Michael H Tollon, Leo B Zadecky, Li Yun Huang, Liming Zhang, Linda L Green, Lisa M Bellows, Lori A Holmquist, Lori M Newman, Luis Mburgos Medero, Lydia I Rosas Marty, Maotang Zhou, PhD, Marcus A Ray, Margaret M Sands, Mariza M Jafary, Mark E Parmon, Mark R Mcclain, Mary Jeanet Mcgarry, Maryam Tabatabaie, Massoud Motamed, Matthew B Casale, Matthew C Watson, Matthew D Silverman, Maura Rooney, Maya M Davis, Megan A Haggerty, Melissa J Garcia, Melissa T Roy, Meredith L Miller, Michael E Maselli, Michael J Casey, Michael L Casner, Michael P Anthony, Michael P Sheehan, Michael Serrano, Michele L Forster, PhD, Michele L Obert, Michelle A Marsh, Michelle M Noe Varga, Michelle Marsh, Michelle Yclark Stuart, Miguel A Martinez Perez, Mihaly S Ligmond, Mindy M Chou, Nadeem I Chaudhry, Nancy G Schmidt, Nancy M Espinal, Nancy T Waites, Nealie C Newberger, Nicholas L Hunt, Nicole K Trudel, Niketa Patel, Obinna R Echeozo, Paraluman S Leonin, Patricia F Hughes, PhD, Patrick C Klotzbuecher, Patsy J Domingo, Paul A Bonneau, Paul L Bellamy, Paula A Trost, Paula J Bretz, Paula M Laplant, Philip F Istafanos, DMV, MS, Philip Kreiter, Prabhu P Raju, Pratik S Upadhyay, DDC, Qin Xu, Qing Joanna Zhou, PhD, Rabin N Ghoshal, Rachael A Moliver, Rachael O Oyewole, Rajiv R Srivastava, Ramon E Martinez, Rebecca E Dombrowski, Reyes Candau Chacon, PhD, Richard A Abate, Richard B Mcaroy, Richard H Penta, Robert C Steyert, Robert J Martin, Robert O'brian, Rory K Geyer, Russell J Glapion, Russell K Riley, Samir C Gala, Samuel J Arsenault, Sandra P White, Scott C Lute, Sean R Marcsisin, Sharon K Thoma, PharmD, Shirley S Wen, Simone E Pitts, Sixto M Mercado Rios, Sneha S Patel, Sony Mathews, Stacey S Degarmo, Stacie A Woods, Stephen C Smith, Stephen R Souza, Steven P Donald, Susan M Jackson, Susanne M Richardson, MS RAC, Suzanne M Healy, Tamika White, Tamil Arasu, PhD, Terry Bridgewater, Thomas J Arista, Timothy T Kapsala, Tonia F Bernard, Toyin B Oladimeji, Troy R Petrillo, Victor J Gangi, Victoria M Daddeo, Wayne E Seifert, William A Warnick, William L Bargo, Ying Xin Fan, PhD, Ze Peng

John P Mistler's Documents

Publish Date Document Type Title
March, 2017 FDA 483 Putney Inc. - Form 483, 2017-03-09
January, 2017 FDA 483 Shire Human Genetic Therapies, Inc. - Form 483, 2017-01-20
October, 2023 FDA 483 Response SCA Pharmaceuticals, LLC - Form 483R, 2023-11-10
April, 2018 FDA 483 Response Berkshire Sterile Manufacturing, Inc. - Form 483R, 2018-05-04
February, 2016 FDA 483 Anderson Holdings Inc. - Form 483, 2016-02-19
April, 2018 EIR Berkshire Sterile Manufacturing, Inc. - EIR, 2018-04-13
January, 2016 FDA 483 Central Admixture Pharmacy Services, Inc. - Form 483, 2016-01-29
April, 2019 FDA 483 PETNET SOLUTIONS, INC. - Form 483, 2019-04-19
April, 2016 EIR Azurity Pharmaceuticals, Inc. - EIR, 2016-04-19
June, 2017 FDA 483 Aztex Enterprises Ltd. - Form 483, 2017-06-13
October, 2015 FDA 483 Genoa Healthcare of Connecticut, LLC - Form 483, 2015-10-05
February, 2018 FDA 483 Lynnfield Drug, Inc. dba Freedom Fertility Pharmacy - Form 483, 2018-02-27
February, 2019 FDA 483 Global Calcium Private Limited - Form 483, 2019-02-22
October, 2016 FDA 483 DCA, Inc. DBA Beacon Prescriptions - Form 483, 2016-10-25
August, 2015 FDA 483 Mytilini Enterprises LLC dba Bedford Pharmacy Inc. - Form 483, 2015-08-28
October, 2016 FDA 483 Tropical Products Inc - Form 483, 2016-10-14
April, 2018 FDA 483 Berkshire Sterile Manufacturing, Inc. - Form 483, 2018-04-13
February, 2016 FDA 483 Response Anderson Holdings Inc. - Form 483R, 2016-02-29
November, 2014 FDA 483 Genzyme Corporation - Form 483, 2014-11-21
July, 2016 FDA 483 AMAG Pharmaceuticals, Inc. - Form 483, 2016-07-15
January, 2019 EIR Element Materials Technology Boston - Acton Inc - EIR, 2019-01-15
January, 2019 FDA 483 Response Element Materials Technology Boston - Acton Inc - Form 483R, 2019-01-15
December, 2019 EIR Avista Pharma Solutions, Inc. dba Cambrex - EIR, 2019-12-18
February, 2019 EIR Global Calcium Private Limited - EIR, 2019-02-22
March, 2020 FDA 483 Response Edge Pharma, LLC - Form 483R, 2020-05-01
November, 2019 EIR AbbVie Bioresearch Center - EIR, 2019-11-18
June, 2019 FDA 483 MASSACHUSETTS GENERAL HOSPITAL, THE - Form 483, 2019-06-17
October, 2015 FDA 483 Genoa, a QoL Healthcare Company, LLC - Form 483, 2015-10-05
August, 2017 FDA 483 Mytilini Enterprises LLC dba Bedford Pharmacy Inc. - Form 483, 2017-08-17
April, 2015 EIR Lyophilization Services Of New England, Inc. (LSNE) - EIR, 2015-04-24
October, 2023 FDA 483 SCA Pharmaceuticals, LLC - Form 483, 2023-10-20
May, 2017 FDA 483 ARIAD Pharmaceuticals - Form 483, 2017-05-31
December, 2017 EIR Azurity Pharmaceuticals, Inc. - EIR, 2017-12-20
February, 2017 EIR Lyophilization Services Of New England, Inc. (LSNE) - EIR, 2017-02-15
December, 2019 FDA 483 Response Avista Pharma Solutions, Inc. dba Cambrex - Form 483R, 2020-01-07
May, 2017 FDA 483 Cambridge Isotope Laboratories, Inc. - Form 483, 2017-05-01
October, 2018 FDA 483 Johnson Memorial Cancer Center - Form 483, 2018-10-19
August, 2017 FDA 483 Response Mytilini Enterprises LLC dba Bedford Pharmacy Inc. - Form 483R, 2017-10-22
January, 2019 FDA 483 Element Materials Technology Boston - Acton Inc - Form 483, 2019-01-15
May, 2019 FDA 483 Squire Laboratories - Form 483, 2019-05-03
September, 2017 FDA 483 Anika Therapeutics Inc - Form 483, 2017-09-21
July, 2019 FDA 483 Mylan Pharmaceuticals Inc. - Form 483, 2019-07-25
June, 2016 FDA 483 EMD Serono, Inc. - Form 483, 2016-06-17
March, 2020 FDA 483 Edge Pharma, LLC - Form 483, 2020-03-30
February, 2016 FDA 483 Sheffield Pharmaceuticals LLC - Form 483, 2016-02-18
September, 2019 FDA 483 Bayer Weimar GmbH und Co. KG - Form 483, 2019-09-13
April, 2017 FDA 483 Biogen, Inc. - Form 483, 2017-04-06
December, 2019 FDA 483 Avista Pharma Solutions, Inc. dba Cambrex - Form 483, 2019-12-18
December, 2018 FDA 483 Fresenius Kabi Compounding, LLC - Form 483, 2018-12-04

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more